Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports
Continued increase in citation impact for journals publishing COVID-19 research LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annualJourna...
Clarivate Annual Sustainability Report Highlights 2021 Milestones, Establishes Sustainability as Strategic Business Imperative
Revealing impact across all 17 United Nations Sustainable Development Goals with 46% of revenues attributable to SDGs LONDON, May 24, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today publishe...
Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients
Winners include Liberty Hospital, four Ardent Health Services hospitals, University of Iowa Hospitals & Clinics and Novant Health LONDON, April 4, 2022 /PRNewswire/ -- Today, Clarivate Healthcare Business InsightsTM , a part of Clarivate Plc (NYSE: CLVT), a global leader in providing trusted inf...
Clarivate Launches New Report on the Research Profile of Central Europe
LONDON, March 30, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launches a new Global Research Report from the Institute for Scientific Information which outlines the research landscape of ...
Clarivate Patient Centricity Report Underscores Need for Evolution from Selling Products to Building Relationships
LONDON, March 23, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of a new report,Walking the talk on patient centricity: An actionable and measurable model for life sc...
Clarivate Deals Report Highlights Emerging Trends in Biopharma Deal-Making
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology related deals dominate the landscape Biotech companies in U.S. awarded largest sums of capital, followed by Mainland China and UK LONDON, March 14, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in provid...
Asia Extends Dominance in Global Innovation Ecosystem, Signals New Era for Innovation, Reveals Top 100 Global Innovators 2022 from Clarivate
Companies from Japan constitute more than a third of the list as the shape and pace of global innovation continues to shift east LONDON, Feb. 23, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, to...
BioWorld by Clarivate Provides In-depth Analyses of Long COVID Studies, Potentially the Next Public Health Crisis
40-plus therapeutics in development even as researchers are trying to reach consensus on the syndrome LONDON, Feb. 17, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has ann...
Clarivate Opens Applications for the Eugene Garfield Award for Innovation in Citation Analysis 2022
LONDON, Feb. 16, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today opened applications for The Eugene Garfield Award™, which recognizes early-career scientists working on innovative approaches ...
Clarivate Identifies Seven Medtech Trends to Watch in 2022
LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...
Clarivate Launches New Global Research Report on Managing Academic Publication Credit in a Collaborative World
LONDON, Jan. 26, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released anew report from the company's Institute for Scientific Information™ which proposes a new method for analyzing the cr...
Clarivate Patent Trend Report Shows Increasing Business Focus on Innovation Through Patent Portfolio Spend
Global organizations cite patent innovation as key to increasing competitive advantage amidst the pandemic LONDON, Jan. 18, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new re...
Clarivate Announces Change in Leadership Structure
LONDON, Jan. 10, 2022 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that as part of its One Clarivate Vision to put even greater focus on its customers and solutions, effectiveFebruar...
Clarivate Identifies Seven Potential Blockbuster Drugs in Annual Drugs to Watch Report
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma Report also examines key therapeutic development areas to watch including mRNA, CRISPR, AI-driven drug discovery and more LONDON, Jan. 10, 2022 /...
Clarivate Acquires Patient Connect, Furthering Position as a Leading Provider of Patient-Centric Solutions
Expanded global offerings allow life science companies to make confident, data-driven decisions tailored to their patient populations LONDON, Dec. 22, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovatio...
Clarivate Named Among Best Companies to Work for in Asia 2021 by HR Asia
Recognition for world-class colleague engagement and workplace excellence LONDON, Dec. 21, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has been named among the Best Companies to Work for inAsi...
Clarivate and KAIST Innovation Strategy and Policy Institute Release Report on the Global AI Innovation Landscape
LONDON, Dec. 20, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation and theKAIST Innovation Strategy and Policy Institute (ISPI) has launched areport in Korea on the global innovation landscape of arti...
BioWorld by Clarivate Identifies the Top Six Global Biopharmaceutical Stories and Trends of 2021
Advances in Alzheimer's, innovation in DNA vaccines, increased regulatory collaboration and the evolving impact of Artificial Intelligence, join Covid-19 as key stories and trends of 2021 LONDON, Dec. 16, 2021 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in pr...
Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China Release Annual Joint Report to Identify 186 Engineering Fronts
LONDON, Dec. 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, theChinese Academy of Engineering (CAE), and the Higher Education Press of China today released their fifth annual collaborative re...
Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 171 Research Fronts
Selecting 110 hot and 61 emerging research specialties in 11 areas of sciences and socialsciences LONDON, Dec. 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, and theChinese Academy of Science...
